Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage i non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysis

European Journal of Cancer

Volumn 50, Issue 17, 2014, Pages 2932-2938

  Matsuo, Yukinori ^a   Chen, Fengshi ^a   Hamaji, Masatsugu ^a   Kawaguchi, Atsushi ^a   Ueki, Nami ^a   Nagata, Yasushi ^b   Sonobe, Makoto ^a   Morita, Satoshi ^a   Date, Hiroshi ^a   Hiraoka, Masahiro ^a  

^a KYOTO UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Minimally invasive surgery; Non small cell lung cancer; Propensity score; Stereotactic body radiotherapy; Treatment outcome

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER PATIENT; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CAUSE OF DEATH; CHARLSON COMORBIDITY INDEX; COMORBIDITY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GENDER; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; LONG TERM SURVIVAL; LUNG LOBECTOMY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; MEDICAL RECORD REVIEW; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPENSITY SCORE; PROPENSITY SCORE MATCHING; RADIATION DOSE; STEREOTACTIC BODY RADIATION THERAPY; SUBLOBAR RESECTION; TREATMENT OUTCOME; VERY ELDERLY; CARCINOMA, NON-SMALL-CELL LUNG; COMPARATIVE STUDY; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIOSURGERY; RETROSPECTIVE STUDY; RISK FACTOR; TUMOR RECURRENCE;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROPENSITY SCORE; RADIOSURGERY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84922481377     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2014.09.006     Document Type: Article

References (35)

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide. IARC Cancer Base No 11 2013. Available from: < http://globocan.iarc.fr > [accessed on May 22, 2014].
2. National Lung Screening Trial Research Team Results of initial low-dose computed tomographic screening for lung cancer N Engl J Med 368 2013 1980 1991
3. V.A. Moyer Screening for lung cancer: U.S. Preventive services task force recommendation statement Ann Intern Med 160 2014 330 338
4. S. Senan, M.A. Paul, and F.J. Lagerwaard Treatment of early-stage lung cancer detected by screening: surgery or stereotactic ablative radiotherapy? Lancet Oncol 14 2013 e270 e274
5. P.E. Van Schil, and J. Van Meerbeeck Surgery or radiotherapy for early-stage lung cancer-a potential comparison bias Lancet Oncol 14 2013 e390
6. D. Moghanaki, and T. Karas Surgery versus SABR for NSCLC Lancet Oncol 14 2013 e490 e491
7. Foundation for Promotion of Cancer Research. Cancer Statistics in Japan - 2013. Available from: < http://ganjoho.jp/pro/statistics/en/backnumber/2013-en.html > [accessed on May 22, 2014].
8. R. Siegel, J. Ma, Z. Zou, and A. Jemal Cancer statistics, 2014 CA Cancer J Clin 64 2014 9 29
9. J.A. Howington, M.G. Blum, A.C. Chang, A.A. Balekian, and S.C. Murthy Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed.: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 143 2013 e278S e313S
10. National Comprehensive Cancer Network. Non-Small Cell Lung Cancer Version 3.2014. NCCN Guidelines 2014. Available from: < http://www.nccn.org/professionals/physician-gls/pdf/nscl.pdf > [accessed on May 22, 2014].
11. A.G. Pallis, C. Gridelli, U. Wedding, C. Faivre-Finn, G. Veronesi, and M. Jaklitsch Management of elderly patients with NSCLC; updated expert's opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology Ann Oncol 25 2014 1270 1283
12. S. Wang, M.L. Wong, N. Hamilton, J. Ben Davoren, T.M. Jahan, and L.C. Walter Impact of age and comorbidity on non-small-cell lung cancer treatment in older veterans J Clin Oncol 30 2012 1447 1455
13. R.J. Ginsberg, and L.V. Rubinstein Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group Ann Thorac Surg 60 1995 615 622 [discussion 622-3]
14. R. Rami-Porta, and M. Tsuboi Sublobar resection for lung cancer Eur Respir J 33 2009 426 435
15. R. Timmerman, R. Paulus, J. Galvin, J. Michalski, W. Straube, and J. Bradley Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 2010 1070 1076
16. P. Baumann, J. Nyman, M. Hoyer, B. Wennberg, G. Gagliardi, and I. Lax Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy J Clin Oncol 27 2009 3290 3296
17. Y. Nagata, M. Hiraoka, T. Shibata, H. Onishi, M. Kokubo, and K. Karasawa Stereotactic body radiation therapy for T1N0M0 non-small cell lung cancer: first report for inoperable population of a phase II trial by Japan Clinical Oncology Group (JCOG 0403) Int J Radiat Oncol Biol Phys 84 2012 S46
18. C.J.A. Haasbeek, D. Palma, O. Visser, F.J. Lagerwaard, B. Slotman, and S. Senan Early-stage lung cancer in elderly patients: a population-based study of changes in treatment patterns and survival in the Netherlands Ann Oncol 23 2012 2743 2747
19. J. Bartlett A moment of equipoise with stereotactic body radiotherapy J Thorac Oncol 9 2014 e17
20. S. Mahmood, H. Bilal, C. Faivre-Finn, and R. Shah Is stereotactic ablative radiotherapy equivalent to sublobar resection in high-risk surgical patients with stage I non-small-cell lung cancer? Interact Cardiovasc Thorac Surg 17 2013 845 853
21. Y. Matsuo, Y. Nakamoto, Y. Nagata, K. Shibuya, K. Takayama, and Y. Norihisa Characterization of FDG-PET images after stereotactic body radiation therapy for lung cancer Radiother Oncol 97 2010 200 204
22. K. Huang, M. Dahele, S. Senan, M. Guckenberger, G.B. Rodrigues, and A. Ward Radiographic changes after lung stereotactic ablative radiotherapy (SABR) - Can we distinguish recurrence from fibrosis? A systematic review of the literature Radiother Oncol 102 2012 335 342
23. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
24. K. Takayama, Y. Nagata, Y. Negoro, T. Mizowaki, T. Sakamoto, and M. Sakamoto Treatment planning of stereotactic radiotherapy for solitary lung tumor Int J Radiat Oncol Biol Phys 61 2005 1565 1571
25. Y. Matsuo, K. Shibuya, Y. Nagata, K. Takayama, Y. Norihisa, and T. Mizowaki Prognostic factors in stereotactic body radiotherapy for non-small-cell lung cancer Int J Radiat Oncol Biol Phys 79 2011 1104 1111
26. M. Schemper, and T.L. Smith A note on quantifying follow-up in studies of failure time Control Clin Trials 17 1996 343 346
27. I.S. Grills, V.S. Mangona, R. Welsh, G. Chmielewski, E. McInerney, and S. Martin Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer J Clin Oncol 28 2010 928 935
28. B. Parashar, P. Patel, S. Monni, P. Singh, N. Sood, and S. Trichter Limited resection followed by intraoperative seed implantation is comparable to stereotactic body radiotherapy for solitary lung cancer Cancer 116 2010 5047 5053
29. J. Varlotto, A. Fakiris, J. Flickinger, L. Medford-Davis, A. Liss, and J. Shelkey Matched-pair and propensity score comparisons of outcomes of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgery Cancer 119 2013 2683 2691
30. S.M. Shirvani, J. Jiang, J.Y. Chang, J.W. Welsh, D.R. Gomez, and S. Swisher Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly Int J Radiat Oncol Biol Phys 84 2012 1060 1070
31. T. Crabtree, V. Puri, R. Timmerman, H. Fernando, J. Bradley, and P.A. Decker Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033) J Thorac Cardiovasc Surg 145 2013 692 699
32. A. Chi, Z. Liao, N.P. Nguyen, J. Xu, B. Stea, and R. Komaki Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications Radiother Oncol 94 2010 1 11
33. N. Ueki, Y. Matsuo, K. Shibuya, M. Nakamura, M. Narabayashi, and K. Sakanaka Differences in the dose-volume metrics with heterogeneity correction status and its influence on local control in stereotactic body radiation therapy for lung cancer J Radiat Res 54 2013 337 343
34. N. Mehta, C.R. King, N. Agazaryan, M. Steinberg, A. Hua, and P. Lee Stereotactic body radiation therapy and 3-dimensional conformal radiotherapy for stage I non-small cell lung cancer: a pooled analysis of biological equivalent dose and local control Pract Radiat Oncol 2 2012 288 295
35. I.S. Grills, A.J. Hope, M. Guckenberger, L.L. Kestin, M. Werner-Wasik, and D. Yan A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy J Thorac Oncol 7 2012 1382 1393